Bayer Aktie

57,52EUR 0,87EUR 1,54%
Bayer hier für 0 Euro handeln mit finanzen.net zero
WKN DE: BAY001 / ISIN: DE000BAY0017
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 100,00
Temasek Holdings Pte Ltd. (Investment Management) 3,52
Norges Bank Investment Management 2,98

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020 2021
Personal am Ende des Jahres 99 762 116 998 103 824 99 538 99 637
Umsatz pro Mitarbeiter in Mio. EUR 0,35 0,34 0,42 0,42 0,44

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020 2021
Summe Umlaufvermögen 31 238 32 197 31 760 35 002 31 994
Summe Anlagevermögen 50 534 87 199 86 308 72 154 73 823
Summe Aktiva 76 820 131 439 131 327 122 850 126 778

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020 2021
Gesamtverschuldung/ -verbindlichkeiten 13 733 41 222 38 971 41 630 40 803
Summe Fremdkapital 39 959 85 291 83 810 92 151 93 610
Summe Eigenkapital 36 861 46 148 47 517 30 699 33 168
Summe Passiva 76 820 131 439 131 327 122 850 126 778

Adresse

Kaiser-Wilhelm-Allee 1, 51368 Leverkusen
Telefon +49 (214) 30-1
Internet http://www.bayer.com

Management

Alan Schultz
Head-North America Project Procurement
Alberto Weisser
Member-Supervisory Board
Andrea Sacher
Member-Supervisory Board
André van Broich
Member-Supervisory Board
Bijoy Sagar
Chief Information Technology Officer
Christian Rommel
Head-Research & Development
Colleen A. Goggins
Member-Supervisory Board
Ertharin Cousin
Member-Supervisory Board
Fei-Fei Li
Member-Supervisory Board
Frank Löllgen
Member-Supervisory Board
Frank Rittgen
Head-Mergers & Acquisitions
Heike Hausfeld
Member-Supervisory Board
Heiko Willem-Jan Schipper
Member-Management Board
Horst Heinz Paul Baier
Member-Supervisory Board
Itziar Canamasas
Head-Oncology Europe, Middle East & Africa
Jürgen Beunink
Senior Manager-Investor Relations
Marianne de Backer
EVP & Head-Global Business Development & Licensing
Martin Hendrix
Senior Director-Business Strategy
Michael Schmidt-Kiessling
Member-Supervisory Board
Norbert W. Bischofberger
Member-Supervisory Board
Norbert Winkeljohann
Chairman-Supervisory Board
Oliver Maier
Head-Investor Relations
Oliver Zühlke
Vice Chairman-Supervisory Board
Otmar D. Wiestler
Member-Supervisory Board
Paul Achleitner
Member-Supervisory Board
Petra Reinbold-Knape
Member-Supervisory Board
Reiner Hoffmann
Member-Supervisory Board
Robert Gundlach
Member-Supervisory Board
Rodrigo Santos
President-Crop Science Division
Ruzha Draganova
Global HR Business Partner
Sarena S. Lin
Chief Transformation & Talent Officer
Simone Bagel-Trah
Member-Supervisory Board
Stefan Oelrich
President-Pharmaceuticals Division
Thomas Elsner
Member-Supervisory Board
Thomas Hoffmann
Head-Treasury
Werner Baumann
Chairman-Management Board & CEO
Wolfgang U. Nickl
Chief Financial Officer